20 results on '"Cobo, S."'
Search Results
2. Self-assembled dimethyldihydropyrene-pyridyl substituted ligands with zinc(ii) meso-tetraphenylporphyrin via axial coordination.
3. 141MO Pathological response and early survival data according to TNBCtype4 classifier in operable triple-negative breast cancer (TNBC) treated with neoadjuvant carboplatin and docetaxel.
4. Nutritional support and risk factors of appearance of enterocutaneous fistulas].
5. Soporte nutricional y factores de riesgo de aparición de fístulas enterocutáneas.
6. TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy.
7. 237MO TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy without immunotherapy.
8. 281P Prevalence of HER2-low breast cancer in the GEICAM/2011-06 trial: Agreement in HER2-low classification between standardized immunohistochemistry assays.
9. 258P Correlation between pathological complete response (pCR) following neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) with or without pertuzumab (TCHP) and PAM50 subtypes in HER2(+) early breast cancer (eBC).
10. 233P Germline genetic testing before formal counseling: Impact in cancer management in a Spanish university hospital.
11. Electrochemical control of the switching process of photochromic dimethyldihydropyrene derivatives.
12. Heart Rate Variability: a Follow-up in Elite Soccer Players Throughout the Season.
13. Heart Rate Variability: a Follow-up in Elite Soccer Players Throughout the Season.
14. Effects of Eccentric Overload Bout on Change of Direction and Performance in Soccer Players.
15. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
16. Standard parenteral nutrition preparations and caloric adjustment.
17. Preparados estándar de nutrición parenteral y ajuste calórico.
18. 53P Activity of chemotherapy drugs in patient-derived xenografts (PDXs) from chemotherapy naïve local-regional triple negative breast cancer (LR-TNBC) patients.
19. 942 - The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG
20. 402 Characterization of Natural Killer cell response to BCG in non-muscle invasive bladder cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.